Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 3, 1996, Pages 265-269

  Levi, Michael ^a,b   Rudén, Ulla ^a   Wahren, Britta ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; SYNTHETIC PEPTIDE; THROMBOSPONDIN; VIRUS ANTIBODY; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; ENZYME IMMUNOASSAY; EPITOPE MAPPING; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029950715     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.3.265-269.1996     Document Type: Article

References (14)

1. Ashley, R. L., J. Militoni, F. Lee, A. Nahmias, and L. Corey. 1988. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26:662-667.
2. De Clercq, E. 1993. Antivirals for the treatment of herpesvirus infections. J. Antimicrob. Chemotherapy. 32(Suppl. A):121-132.
3. Field, P. R., D. W. T. Ho, W. L. Irving, D. Isaacs, and A. L. Cunningham. 1993. The reliability of serological tests for the diagnosis of genital herpes: a critique. Pathology 25:175-179.
4. Ho, D. W. T., P. R. Field, W. L. Irving, D. R. Packham, and A. L. Cunningham. 1993. Detection of immunoglobulin M antibodies to glycoprotein G-2 by Western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J. Clin. Microbiol. 31:3157-3164.
5. Ho, D. W. T., P. R. Field, E. Sjögren-Jansson, S. Jeansson, and A. L. Cunningham. 1992. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J. Virol. Methods 36:249-264.
6. McGeoch, D. J., H. W. M. Moss, D. McNab, and M. C. Frame. 1987. DNA sequence and genetic content of the HindIII1 region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J. Gen. Virol. 68:19-38.
7. Munoz, N., I. Kato, F. X. Bosch, S. De Sanjosé, V.-A. Sundquist, I. Izarzugaza, L. C. Gonzalez, L. Tafur, M. Gili, P. Viladiu, C. Navarro, P. Moreo, E. Guerrero, K. V. Shah, and B. Wahren. 1995. Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia with special reference to immunoglobulin-G subclasses. Int. J. Cancer 60:438-442.
8. Olofsson, S., S. Jeansson, and E. Lycke. 1981. Unusual lectin-binding properties of a herpes simplex virus type 1-specific glycoprotein. J. Virol. 38:564-570.
9. Olofsson, S., M. Lundström, H. Marsden, S. Jeansson, and A. Vahlne. 1986. Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG. J. Gen. Virol. 67:737-744.
10. Parkes, D. L., C. M. Smith, J. M. Rose, J. Brandis, and S. R. Coates. 1991. Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. J. Clin. Microbiol. 29:778-781.
11. Roizman, B., R. J. Whitley, and C. Lopez. 1993. The human herpes viruses. Raven Press, New York.
12. Sánchez-Martínez, D., and P. E. Pellett. 1991. Expression of HSV-1 and HSV-2 glycoprotein G in insect cells by using a novel baculovirus expression vector. Virology 182:229-238.
13. Straus, S. E., L. Corey, R. L. Burke, B. Savarese, G. Barnum, P. R. Krause, R. G. Kost, J. L. Meier, R. Sekulovich, S. F. Adair, and C. L. Dekker. 1994. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343:1460-1463.
14. Straus, S. E., B. Savarese, M. Tigges, A. G. Freifeld, P. R. Krause, D. M. Margolis, J. L. Meier, D. P. Paar, S. F. Adair, D. Dina, C. Dekker, and R. L. Burke. 1993. Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine. J. Infect. Dis. 167:1045-1052.